A synthetic pentapeptide that has effects like gastrin when given parenterally. It stimulates the secretion of gastric acid, pepsin, and intrinsic factor, and has been used as a diagnostic aid.
The liquid secretion of the stomach mucosa consisting of hydrochloric acid (GASTRIC ACID); PEPSINOGENS; INTRINSIC FACTOR; GASTRIN; MUCUS; and the bicarbonate ion (BICARBONATES). (From Best & Taylor's Physiological Basis of Medical Practice, 12th ed, p651)
Hydrochloric acid present in GASTRIC JUICE.
Formed from pig pepsinogen by cleavage of one peptide bond. The enzyme is a single polypeptide chain and is inhibited by methyl 2-diaazoacetamidohexanoate. It cleaves peptides preferentially at the carbonyl linkages of phenylalanine or leucine and acts as the principal digestive enzyme of gastric juice.
The amount of a substance secreted by cells or by a specific organ or organism over a given period of time; usually applies to those substances which are formed by glandular tissues and are released by them into biological fluids, e.g., secretory rate of corticosteroids by the adrenal cortex, secretory rate of gastric acid by the gastric mucosa.
Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones.
A histamine H2 receptor antagonist that is used as an anti-ulcer agent.
Bethanechol compounds are parasympathomimetic agents that directly stimulate muscarinic receptors, primarily used to treat urinary retention and nonobstructive bladder dysfunction by increasing bladder contractility and decreasing post-void residual volume.
A family of gastrointestinal peptide hormones that excite the secretion of GASTRIC JUICE. They may also occur in the central nervous system where they are presumed to be neurotransmitters.
Cell surface proteins that bind cholecystokinin (CCK) with high affinity and trigger intracellular changes influencing the behavior of cells. Cholecystokinin receptors are activated by GASTRIN as well as by CCK-4; CCK-8; and CCK-33. Activation of these receptors evokes secretion of AMYLASE by pancreatic acinar cells, acid and PEPSIN by stomach mucosal cells, and contraction of the PYLORUS and GALLBLADDER. The role of the widespread CCK receptors in the central nervous system is not well understood.
An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter.
Rapidly decreasing response to a drug or physiologically active agent after administration of a few doses. In immunology, it is the rapid immunization against the effect of toxic doses of an extract or serum by previous injection of small doses. (Dorland, 28th ed)
A drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers.
A PEPTIC ULCER located in the DUODENUM.
An organ of digestion situated in the left upper quadrant of the abdomen between the termination of the ESOPHAGUS and the beginning of the DUODENUM.
A group of compounds that are derivatives of beta-methylacetylcholine (methacholine).
Benzodiazepinones are a class of psychoactive drugs that bind to the GABA-A receptor and enhance its inhibitory effects, producing anxiolytic, sedative, hypnotic, anticonvulsant, and muscle relaxant properties.
The region between the sharp indentation at the lower third of the STOMACH (incisura angularis) and the junction of the PYLORUS with the DUODENUM. Pyloric antral glands contain mucus-secreting cells and gastrin-secreting endocrine cells (G CELLS).
The interruption or removal of any part of the vagus (10th cranial) nerve. Vagotomy may be performed for research or for therapeutic purposes.
Vagal denervation of that part of the STOMACH lined with acid-secreting mucosa (GASTRIC MUCOSA) containing the GASTRIC PARIETAL CELLS. Since the procedure leaves the vagal branches to the antrum and PYLORUS intact, it circumvents gastric drainage required with truncal vagotomy techniques.
A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety.
A derivative of benzodiazepine that acts on the cholecystokinin A (CCKA) receptor to antagonize CCK-8's (SINCALIDE) physiological and behavioral effects, such as pancreatic stimulation and inhibition of feeding.
The increase in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical.
L-Tryptophyl-L-methionyl-L-aspartyl-L-phenylalaninamide. The C-terminal tetrapeptide of gastrin. It is the smallest peptide fragment of gastrin which has the same physiological and pharmacological activity as gastrin.
A slowly hydrolyzing muscarinic agonist with no nicotinic effects. Bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, HEART RATE changes, and BRONCHIAL SPASM.
A peptide hormone of about 27 amino acids from the duodenal mucosa that activates pancreatic secretion and lowers the blood sugar level. (USAN and the USP Dictionary of Drug Names, 1994, p597)
Abnormal passage communicating with the STOMACH.
A 3:1 mixture of alfaxalone with alfadolone acetate that previously had been used as a general anesthetic. It is no longer actively marketed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1445)
Gastric analysis for determination of free acid or total acid.
An alkaloid, originally from Atropa belladonna, but found in other plants, mainly SOLANACEAE. Hyoscyamine is the 3(S)-endo isomer of atropine.
The area covering the terminal portion of ESOPHAGUS and the beginning of STOMACH at the cardiac orifice.
A subtype of cholecystokinin receptor found primarily in the CENTRAL NERVOUS SYSTEM and the GASTRIC MUCOSA. It may play a role as a neuromodulator of dopaminergic neurotransmission the regulation of GASTRIC ACID secretion from GASTRIC PARIETAL CELLS.
A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults.
An octapeptide hormone present in the intestine and brain. When secreted from the gastric mucosa, it stimulates the release of bile from the gallbladder and digestive enzymes from the pancreas.
A photographic fixative used also in the manufacture of resins. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance may reasonably be anticipated to be a carcinogen (Merck Index, 9th ed). Many of its derivatives are ANTITHYROID AGENTS and/or FREE RADICAL SCAVENGERS.
Derived proteins or mixtures of cleavage products produced by the partial hydrolysis of a native protein either by an acid or by an enzyme. Peptones are readily soluble in water, and are not precipitable by heat, by alkalis, or by saturation with ammonium sulfate. (Dorland, 28th ed)
A motility disorder of the ESOPHAGUS in which the LOWER ESOPHAGEAL SPHINCTER (near the CARDIA) fails to relax resulting in functional obstruction of the esophagus, and DYSPHAGIA. Achalasia is characterized by a grossly contorted and dilated esophagus (megaesophagus).
The shortest and widest portion of the SMALL INTESTINE adjacent to the PYLORUS of the STOMACH. It is named for having the length equal to about the width of 12 fingers.
Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood.
A symptom complex associated with CARCINOID TUMOR and characterized by attacks of severe flushing of the skin, diarrheal watery stools, bronchoconstriction, sudden drops in blood pressure, edema, and ascites. The carcinoid tumors are usually located in the gastrointestinal tract and metastasize to the liver. Symptoms are caused by tumor secretion of serotonin, prostaglandins, and other biologically active substances. Cardiac manifestations constitute CARCINOID HEART DISEASE. (Dorland, 27th ed; Stedman, 25th ed)
A state of extreme acute, intense anxiety and unreasoning fear accompanied by disorganization of personality function.
A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal.
The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065)
The secretion of histamine from mast cell and basophil granules by exocytosis. This can be initiated by a number of factors, all of which involve binding of IgE, cross-linked by antigen, to the mast cell or basophil's Fc receptors. Once released, histamine binds to a number of different target cell receptors and exerts a wide variety of effects.
Compounds containing the hexamethylenebis(trimethylammonium) cation. Members of this group frequently act as antihypertensive agents and selective ganglionic blocking agents.
Fluids originating from the epithelial lining of the intestines, adjoining exocrine glands and from organs such as the liver, which empty into the cavity of the intestines.
A type of stress exerted uniformly in all directions. Its measure is the force exerted per unit area. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
The superior portion of the body of the stomach above the level of the cardiac notch.
A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
The relationship between the dose of an administered drug and the response of the organism to the drug.
The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical.
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood.
HORMONES secreted by the gastrointestinal mucosa that affect the timing or the quality of secretion of digestive enzymes, and regulate the motor activity of the digestive system organs.
A 36-amino acid pancreatic hormone that is secreted mainly by endocrine cells found at the periphery of the ISLETS OF LANGERHANS and adjacent to cells containing SOMATOSTATIN and GLUCAGON. Pancreatic polypeptide (PP), when administered peripherally, can suppress gastric secretion, gastric emptying, pancreatic enzyme secretion, and appetite. A lack of pancreatic polypeptide (PP) has been associated with OBESITY in rats and mice.
A lack of HYDROCHLORIC ACID in GASTRIC JUICE despite stimulation of gastric secretion.

Responses of the competent and incompetent lower oesophageal sphincter to pentagastrin and abdominal compression. (1/414)

Responses of the lower oesophageal sphincter (LOS) to pentagastrin, given by continuous intravenous infusion in doses ranging between 0 and 9 mug/kg/h, and to external abdominal compression were measured by infused catheters in healthy subjects and in a group of patients with reflux oesophagitis. In separate experiments, pressures were measured both by sensors stationary within the LOS, and by repeated continuous withdrawals of sensors from stomach to distal oesophagus. In normal subjects, doses of pentagastrin within the physiological range (0.9 mug/kg/h) produced modest but statistically significant increases in LOS pressure. By comparison, sphincteric responses in patients with oesophagitis were small and a dose of 4-5 mug/kg/h was the lowest that produced a significant increase in LOS pressure. During abdominal compression increases in LOS pressure did not significantly exceed increases in intragastric pressure in either patients or normal subjects. This was so at all doses of pentagastrin that were tested. Hence, there was no evidence of synergism between the effects of pentagastrin and abdominal compression upon the LOS. We infer from our findings that gastrin does play a modest role in the physiological regulation of human LOS tone. Relative insensitivity of the incompetent LOS to pentagastrin represents, we believe, sphincteric muscle failure. Our results are not consistent with the hypothesis that LOS incompetence is due to loss or impairment of an adaptive response of the LOS to alterations in intra-abdominal pressure.  (+info)

Predictive value of perioperative gastric acid tests. (2/414)

Preoperative acid studies and early postoperative insulin tests in 275 patients undergoing various forms of vagotomy have been related to recurrent ulceration. Follow-up time has been from two to nine years, mean 4-3 years. Recurrence is directly related to basal acidity in both tests but is not related to stimulated acid levels preoperatively. In the insulin tests higher levels of acidity after insulin are associated with a higher incidence of recurrence. When positive, Hollander's and multiple criteria are both associated with a higher recurrence rate.  (+info)

Characterization of the binding of a novel radioligand to CCKB/gastrin receptors in membranes from rat cerebral cortex. (3/414)

1. We have investigated the binding of a novel radiolabelled CCKB/gastrin receptor ligand, [3H]-JB93182 (5[[[(1S)-[[(3,5-dicarboxyphenyl)amino]carbonyl]-2-phenylethyla mino]-carbonyl]-6-[[(1-adamantylmethyl) amino]carbonyl]-indole), to sites in rat cortex membranes. 2. The [3H]-JB93182 was 97% radiochemically pure as assessed by reverse-phase HPLC (RP-HPLC) and was not degraded by incubation (150 min) with rat cortex membranes. 3. Saturation analysis indicated that [3H]-JB93182 labelled a homogeneous population of receptors in rat cortex membranes (pKD=9.48+/-0.08, Bmax=3.61+/-0.65 pmol g(-1) tissue, nH=0.97+/-0.02, n=5). The pKD was not significantly different when estimated by association-dissociation analysis (pKD=9.73+/-0.11; n=10). 4. In competition studies, the low affinity of the CCKA receptor antagonists, L-364,718; SR27897 and 2-NAP, suggest that, under the assay conditions employed, [3H]-JB93182 (0.3 nM) does not label CCKA receptors in the rat cortex. 5. The affinity estimates obtained for reference CCKB/gastrin receptor antagonists were indistinguishable from one of the affinity values obtained when a two site model was used to interpret [125I]-BH-CCK8S competition curves obtained in the same tissue (Harper et al., 1999). 6. This study provides further evidence for the existence of two CCKB/gastrin sites in rat cortex. [3H]-JB93182 appears to label selectively sites previously designated as gastrin-G1 and therefore it may be a useful compound for the further discrimination and characterization of these putative receptor subtypes.  (+info)

Mast cells and gastric secretion in the rat. (4/414)

Gastric secretion of acid was measured in adult rats deprived of solid food for 48 hr. In control animals, values were obtained for the residual content of acid in the stomach, indicative of the rate of basal secretion, and for the quantities of acid secreted in 30 min following injections of histamine, pentagastrin, insulin and compound 48/80. The same measurements were made in groups of rats treated for 5 days with compound 48/80 (a regime which depleted the whole body of mast cells) and for 3 days with dexamethasone (which selectively depleted the gastric mucosa of mast cells). The content of residual acid was depressed to one third of the control value in the 48/80-treated rats, but the additional secretion due to histamine, pentagastrin or insulin was unaffected. A secretory response to a single injection of compound 48/80 could not be obtained in rats depleted of mast cells. In the dexamethasone-treated rats, the residual level of acid was increased to 1-5 times the control value, but the magnitudes of the responses to secretogogues were unchanged. It is concluded that basal secretion of acid into the stomach of the rat is stimulated by histamine derived from mast cells throughout the body, those of the gastric mucosa having no special significance in this respect. Mast cells are not involved in the mediation of the secretagogue actions of exogenous histamine, pentagastrin and insulin, but the present results do not preclude the participation of histamine from sources other than mast cells in the process of gastric secretion.  (+info)

Synthesis of nitric oxide in the dorsal motor nucleus of the vagus mediates the inhibition of gastric acid secretion by central bombesin. (5/414)

1. Central administration of bombesin inhibits gastric acid production independently of the centrally or peripherally-acting stimuli employed. This study evaluates the role and location of the cerebral nitric oxide (NO) implicated in the inhibitory effect of central bombesin on in vivo rat gastric acid secretion, as induced by distension with 15 cm H2O, insulin (0.75 u.i. kg-1 i.p.) TRH (1.2 microg kg-1, i.c.) or pentagastrin (100 microg kg-1, i.p.). 2. The acid-inhibitory effect of i.c. bombesin (40 ng kg-1) was prevented by prior administration of L-NAME (80 microg kg-1) in the dorsal motor nucleus of the vagus (DMN). This dose of L-NAME when administered into the nucleus of the tractus solitarious (NTS) did not influence the effects of bombesin. Administration of L-arginine (400 microg kg-1) into the DMN restored the acid-inhibitory effect of i.c. bombesin in animals treated with L-NAME. 3. Microinjection of bombesin (12 ng kg-1) into the paraventricular nucleus of the hypothalamus (PvN) inhibits acid secretion stimulated by pentagastrin. This inhibitory effect was prevented by a previous injection of L-NAME (80 microg kg-1) into the DMN. 4. The release of NO in the DMN following i.c. administration of bombesin was confirmed by in vivo electrochemical detection. 5. Administration by microdialysis in the DMN of the NO-donor SNAP (25 mM in 1.5 microl min-1) into the DMN inhibits pentagastrin-stimulated gastric acid secretion. 6. The present study suggests that nNOS-containing neurons in the DMN have an inhibitory role in the control of gastric acid responses.  (+info)

Incidental detection of familial medullary thyroid carcinoma by calcitonin screening for nodular thyroid disease. (6/414)

Serum calcitonin screening has recently been found to be a useful supplement to fine-needle aspiration biopsy, ultrasound and radionuclide imaging in the evaluation of thyroid nodules. We describe a case where introduction of routine calcitonin screening in nodular thyroid disease led to the detection of a family with medullary thyroid carcinoma. The benefits and problems of basal and stimulated serum calcitonin testing and ret-proto-oncogene mutation studies are exemplified and we discuss the appropriate use and interpretation of these tests. We conclude that routine basal serum calcitonin measurement in nodular thyroid disease and thoughtful use of ret-mutation analysis is cost-effective in detecting medullary thyroid carcinoma and multiple endocrine neoplasia type II.  (+info)

Dose response of adrenocorticotropin and cortisol to the CCK-B agonist pentagastrin. (7/414)

Cholecystokinin (CCK) is an abundant neurotransmitter in brain. Its functional significance in humans is incompletely understood, but it may modulate activity in the hypothalamic-pituitary-adrenal (HPA) axis. To explore this hypothesis, we examined the effects of varying doses (0 to 0.8 microgram/kg) of the CCK-B agonist pentagastrin on adrenocorticotropin (ACTH) and cortisol release in healthy human subjects. We also examined anxiety, heart rate (HR), and blood pressure (BP) responses. Pentagastrin induced large (up to 520% increase over baseline), significant and very rapid, dose-dependent elevations in ACTH and cortisol levels. Significant elevations in HR and BP were seen at all doses, without clear dose-response relationships. Anxious distress and symptom responses were also somewhat dose dependent; but hormonal responses were more robustly linked to pentagastrin dose than to these subjective measures. The HPA axis response to the CCK-B agonist pentagastrin may be a direct pharmacological effect. Further work is needed to determine the mechanisms and the physiological significance of CCK-mediated modulation of the human neuroendocrine stress axis.  (+info)

Early or prophylactic thyroidectomy in MEN 2/FMTC gene carriers: results in 71 thyroidectomized patients. The French Calcitonin Tumours Study Group (GETC). (8/414)

BACKGROUND: Once genetic testing accurately identifies MEN 2 gene carriers, affected children are given the opportunity to undergo thyroidectomy at the earliest stages of the C-cell disease. OBJECTIVE: To define reliable parameters by which to identify the best moment for thyroidectomy in patients who are carriers of the MEN 2 gene. PATIENTS AND METHODS: Seventy-one MEN 2/FMTC gene carriers, collected through the national register of the French Calcitonin Tumours Study Group, were evaluated. All the patients included were younger than 20 years of age and underwent total thyroidectomy. Basal and pentagastrin-stimulated calcitonin were assayed using an immunoradiometric method (sensitivity less than 2pg/ml). Calcitonin measurement was evaluated on the basis of histopathological findings in surgical thyroid specimens. RESULTS: We found C-cell hyperplasia or medullary thyroid carcinoma in all the 71 gene carriers - even for the youngest patients - and nodal metastases were present in four cases. Calcitonin measurement (basal or pentagastrin-stimulated) detected C-cell disease preoperatively in all patients. Six of the 71 patients were not surgically cured: one had nodal metastases, one had an advanced staged disease and four had an incomplete nodal dissection or had not undergone lymph node surgery. CONCLUSIONS: Determination of calcitonin forms an integral part of the management of MEN 2 gene carriers. Thyroidectomy is undisputably indicated when basal calcitonin is abnormal. When basal calcitonin is undetectable, a pentagastrin-stimulated increase in calcitonin to more than 10 pg/ml indicates an early thyroidectomy to cure the patient.  (+info)

Pentagastrin is a synthetic polypeptide hormone that stimulates the release of gastrin and hydrochloric acid from the stomach. It is used diagnostically to test for conditions such as Zollinger-Ellison syndrome, a rare disorder in which tumors in the pancreas or duodenum produce excessive amounts of gastrin, leading to severe ulcers and other digestive problems.

Pentagastrin is typically administered intravenously, and its effects are monitored through blood tests that measure gastric acid secretion. It is a potent stimulant of gastric acid production, and its use is limited to diagnostic purposes due to the risk of adverse effects such as nausea, flushing, and increased heart rate.

Gastric juice is a digestive fluid that is produced in the stomach. It is composed of several enzymes, including pepsin, which helps to break down proteins, and gastric amylase, which begins the digestion of carbohydrates. Gastric juice also contains hydrochloric acid, which creates a low pH environment in the stomach that is necessary for the activation of pepsin and the digestion of food. Additionally, gastric juice contains mucus, which helps to protect the lining of the stomach from the damaging effects of the hydrochloric acid. The production of gastric juice is controlled by hormones and the autonomic nervous system.

Gastric acid, also known as stomach acid, is a digestive fluid produced in the stomach. It's primarily composed of hydrochloric acid (HCl), potassium chloride (KCl), and sodium chloride (NaCl). The pH of gastric acid is typically between 1.5 and 3.5, making it a strong acid that helps to break down food by denaturing proteins and activating digestive enzymes.

The production of gastric acid is regulated by the enteric nervous system and several hormones. The primary function of gastric acid is to initiate protein digestion, activate pepsinogen into the active enzyme pepsin, and kill most ingested microorganisms. However, an excess or deficiency in gastric acid secretion can lead to various gastrointestinal disorders such as gastritis, ulcers, and gastroesophageal reflux disease (GERD).

Pepsin A is defined as a digestive enzyme that is primarily secreted by the chief cells in the stomach's fundic glands. It plays a crucial role in protein catabolism, helping to break down food proteins into smaller peptides during the digestive process. Pepsin A has an optimal pH range of 1.5-2.5 for its enzymatic activity and is activated from its inactive precursor, pepsinogen, upon exposure to acidic conditions in the stomach.

Secretory rate refers to the amount or volume of a secretion produced by a gland or an organ over a given period of time. It is a measure of the productivity or activity level of the secreting structure. The secretory rate can be quantified for various bodily fluids, such as saliva, sweat, digestive enzymes, hormones, or milk, depending on the context and the specific gland or organ being studied.

In clinical settings, measuring the secretory rate might involve collecting and analyzing samples over a certain duration to estimate the production rate of the substance in question. This information can be helpful in diagnosing conditions related to impaired secretion, monitoring treatment responses, or understanding the physiological adaptations of the body under different circumstances.

Gastric mucosa refers to the innermost lining of the stomach, which is in contact with the gastric lumen. It is a specialized mucous membrane that consists of epithelial cells, lamina propria, and a thin layer of smooth muscle. The surface epithelium is primarily made up of mucus-secreting cells (goblet cells) and parietal cells, which secrete hydrochloric acid and intrinsic factor, and chief cells, which produce pepsinogen.

The gastric mucosa has several important functions, including protection against self-digestion by the stomach's own digestive enzymes and hydrochloric acid. The mucus layer secreted by the epithelial cells forms a physical barrier that prevents the acidic contents of the stomach from damaging the underlying tissues. Additionally, the bicarbonate ions secreted by the surface epithelial cells help neutralize the acidity in the immediate vicinity of the mucosa.

The gastric mucosa is also responsible for the initial digestion of food through the action of hydrochloric acid and pepsin, an enzyme that breaks down proteins into smaller peptides. The intrinsic factor secreted by parietal cells plays a crucial role in the absorption of vitamin B12 in the small intestine.

The gastric mucosa is constantly exposed to potential damage from various factors, including acid, pepsin, and other digestive enzymes, as well as mechanical stress due to muscle contractions during digestion. To maintain its integrity, the gastric mucosa has a remarkable capacity for self-repair and regeneration. However, chronic exposure to noxious stimuli or certain medical conditions can lead to inflammation, erosions, ulcers, or even cancer of the gastric mucosa.

Metiamide is not generally considered a medical term, but it is a medication that has been used in the past. Medically, metiamide is defined as a synthetic histamine H2-receptor antagonist, which means it blocks the action of histamine at the H2 receptors in the stomach. This effect reduces gastric acid secretion and can be useful in treating gastroesophageal reflux disease (GERD), peptic ulcers, and other conditions associated with excessive stomach acid production.

However, metiamide has largely been replaced by other H2 blockers like cimetidine, ranitidine, and famotidine due to its association with a rare but serious side effect called agranulocytosis, which is a severe decrease in white blood cell count that can increase the risk of infections.

Bethanechol compounds are a type of cholinergic agent used in medical treatment. They are parasympathomimetic drugs, which means they mimic the actions of the neurotransmitter acetylcholine at muscarinic receptors. Specifically, bethanechol compounds stimulate the muscarinic receptors in the smooth muscle of the bladder and gastrointestinal tract, increasing tone and promoting contractions.

Bethanechol is primarily used to treat urinary retention and associated symptoms, such as those that can occur after certain types of surgery or with conditions like spinal cord injury or multiple sclerosis. It works by helping the bladder muscle contract, which can promote urination.

It's important to note that bethanechol should be used with caution, as it can have various side effects, including sweating, increased salivation, flushed skin, and gastrointestinal symptoms like nausea, vomiting, or diarrhea. It may also interact with other medications, so it's crucial to discuss any potential risks with a healthcare provider before starting this treatment.

Gastrins are a group of hormones that are produced by G cells in the stomach lining. These hormones play an essential role in regulating gastric acid secretion and motor functions of the gastrointestinal tract. The most well-known gastrin is known as "gastrin-17," which is released into the bloodstream and stimulates the release of hydrochloric acid from parietal cells in the stomach lining.

Gastrins are stored in secretory granules within G cells, and their release is triggered by several factors, including the presence of food in the stomach, gastrin-releasing peptide (GRP), and vagus nerve stimulation. Once released, gastrins bind to specific receptors on parietal cells, leading to an increase in intracellular calcium levels and the activation of enzymes that promote hydrochloric acid secretion.

Abnormalities in gastrin production can lead to several gastrointestinal disorders, including gastrinomas (tumors that produce excessive amounts of gastrin), which can cause severe gastric acid hypersecretion and ulcers. Conversely, a deficiency in gastrin production can result in hypochlorhydria (low stomach acid levels) and impaired digestion.

Cholecystokinin (CCK) receptors are a type of G protein-coupled receptor that bind to and are activated by the hormone cholecystokinin. CCK is a peptide hormone that is released by cells in the duodenum in response to the presence of nutrients, particularly fat and protein. It has several physiological roles, including stimulating the release of digestive enzymes from the pancreas, promoting the contraction of the gallbladder and relaxation of the sphincter of Oddi (which controls the flow of bile and pancreatic juice into the duodenum), and inhibiting gastric emptying.

There are two main types of CCK receptors, known as CCK-A and CCK-B receptors. CCK-A receptors are found in the pancreas, gallbladder, and gastrointestinal tract, where they mediate the effects of CCK on digestive enzyme secretion, gallbladder contraction, and gastric emptying. CCK-B receptors are found primarily in the brain, where they play a role in regulating appetite and satiety.

CCK receptors have been studied as potential targets for the development of drugs to treat various gastrointestinal disorders, such as pancreatitis, gallstones, and obesity. However, more research is needed to fully understand their roles and therapeutic potential.

Histamine is defined as a biogenic amine that is widely distributed throughout the body and is involved in various physiological functions. It is derived primarily from the amino acid histidine by the action of histidine decarboxylase. Histamine is stored in granules (along with heparin and proteases) within mast cells and basophils, and is released upon stimulation or degranulation of these cells.

Once released into the tissues and circulation, histamine exerts a wide range of pharmacological actions through its interaction with four types of G protein-coupled receptors (H1, H2, H3, and H4 receptors). Histamine's effects are diverse and include modulation of immune responses, contraction and relaxation of smooth muscle, increased vascular permeability, stimulation of gastric acid secretion, and regulation of neurotransmission.

Histamine is also a potent mediator of allergic reactions and inflammation, causing symptoms such as itching, sneezing, runny nose, and wheezing. Antihistamines are commonly used to block the actions of histamine at H1 receptors, providing relief from these symptoms.

Tachyphylaxis is a medical term that refers to the rapid and temporary loss of response to a drug after its repeated administration, especially when administered in quick succession. This occurs due to the decreased sensitivity or responsiveness of the body's receptors to the drug, resulting in a reduced therapeutic effect over time.

In simpler terms, tachyphylaxis is when the body becomes quickly desensitized to a medication after taking it multiple times in a short period, causing the drug to become less effective or ineffective at achieving the desired outcome. This phenomenon can occur with various medications, including those used for treating pain, allergies, and psychiatric conditions.

It's important to note that tachyphylaxis should not be confused with tolerance, which is a similar but distinct concept where the body gradually becomes less responsive to a drug after prolonged use over time.

Proglumide is not a medication that has a widely accepted or commonly used medical definition in current clinical practice. However, historically, it has been described as a synthetic benzamide derivative with antidomaminergic and gastrointestinal properties. It was initially investigated as a potential treatment for various gastrointestinal disorders, such as gastric ulcers, due to its ability to inhibit gastric acid secretion.

Proglumide has been found to act as an antagonist at certain dopamine receptors (D2 and D3) and serotonin receptors (5-HT3), which may contribute to its effects on gastrointestinal motility and gastric acid secretion. However, due to the development of more effective treatments and some uncertainty regarding its efficacy, proglumide is not widely used in modern medical practice.

It is important to note that this information might not be comprehensive or entirely up-to-date, as the use and understanding of proglumide have evolved over time. Always consult a reliable medical source or healthcare professional for the most accurate and current information.

A duodenal ulcer is a type of peptic ulcer that develops in the lining of the first part of the small intestine, called the duodenum. It is characterized by a break in the mucosal layer of the duodinal wall, leading to tissue damage and inflammation. Duodenal ulcers are often caused by an imbalance between digestive acid and mucus production, which can be exacerbated by factors such as bacterial infection (commonly with Helicobacter pylori), nonsteroidal anti-inflammatory drug use, smoking, and stress. Symptoms may include gnawing or burning abdominal pain, often occurring a few hours after meals or during the night, bloating, nausea, vomiting, loss of appetite, and weight loss. Complications can be severe, including bleeding, perforation, and obstruction of the duodenum. Diagnosis typically involves endoscopy, and treatment may include antibiotics (if H. pylori infection is present), acid-suppressing medications, lifestyle modifications, and potentially surgery in severe cases.

In anatomical terms, the stomach is a muscular, J-shaped organ located in the upper left portion of the abdomen. It is part of the gastrointestinal tract and plays a crucial role in digestion. The stomach's primary functions include storing food, mixing it with digestive enzymes and hydrochloric acid to break down proteins, and slowly emptying the partially digested food into the small intestine for further absorption of nutrients.

The stomach is divided into several regions, including the cardia (the area nearest the esophagus), the fundus (the upper portion on the left side), the body (the main central part), and the pylorus (the narrowed region leading to the small intestine). The inner lining of the stomach, called the mucosa, is protected by a layer of mucus that prevents the digestive juices from damaging the stomach tissue itself.

In medical contexts, various conditions can affect the stomach, such as gastritis (inflammation of the stomach lining), peptic ulcers (sores in the stomach or duodenum), gastroesophageal reflux disease (GERD), and stomach cancer. Symptoms related to the stomach may include abdominal pain, bloating, nausea, vomiting, heartburn, and difficulty swallowing.

Methacholine compounds are medications that are used as a diagnostic tool to help identify and confirm the presence of airway hyperresponsiveness in patients with respiratory symptoms such as cough, wheeze, or shortness of breath. These compounds act as bronchoconstrictors, causing narrowing of the airways in individuals who have heightened sensitivity and reactivity of their airways, such as those with asthma.

Methacholine is a synthetic derivative of acetylcholine, a neurotransmitter that mediates nerve impulse transmission in the body. When inhaled, methacholine binds to muscarinic receptors on the smooth muscle surrounding the airways, leading to their contraction and narrowing. The degree of bronchoconstriction is then measured to assess the patient's airway responsiveness.

It is important to note that methacholine compounds are not used as therapeutic agents but rather as diagnostic tools in a controlled medical setting under the supervision of healthcare professionals.

Benzodiazepines are a class of psychoactive drugs that possess anxiolytic, anticonvulsant, amnesic, sedative, hypnotic, and muscle relaxant properties. Benzodiazepinones are a subclass of benzodiazepines that share a specific chemical structure, characterized by a 1,4-benzodiazepine ring with an additional nitrogen-containing ring attached at the 2-position of the benzodiazepine ring.

Examples of benzodiazepinones include clonazepam (Klonopin), diazepam (Valium), and flurazepam (Dalmane). These medications are commonly used in the treatment of anxiety disorders, insomnia, seizures, and muscle spasms. However, they can also cause physical dependence and withdrawal symptoms, so they should be prescribed with caution and under medical supervision.

The pyloric antrum is the distal part of the stomach, which is the last portion that precedes the pylorus and the beginning of the duodenum. It is a thickened, muscular area responsible for grinding and mixing food with gastric juices during digestion. The pyloric antrum also helps regulate the passage of chyme (partially digested food) into the small intestine through the pyloric sphincter, which controls the opening and closing of the pylorus. This region is crucial in the gastrointestinal tract's motor functions and overall digestive process.

A vagotomy is a surgical procedure that involves cutting or blocking the vagus nerve, which is a parasympathetic nerve that runs from the brainstem to the abdomen and helps regulate many bodily functions such as heart rate, gastrointestinal motility, and digestion. In particular, vagotomy is often performed as a treatment for peptic ulcers, as it can help reduce gastric acid secretion.

There are several types of vagotomy procedures, including:

1. Truncal vagotomy: This involves cutting the main trunks of the vagus nerve as they enter the abdomen. It is a more extensive procedure that reduces gastric acid secretion significantly but can also lead to side effects such as delayed gastric emptying and diarrhea.
2. Selective vagotomy: This involves cutting only the branches of the vagus nerve that supply the stomach, leaving the rest of the nerve intact. It is a less extensive procedure that reduces gastric acid secretion while minimizing side effects.
3. Highly selective vagotomy (HSV): Also known as parietal cell vagotomy, this involves cutting only the branches of the vagus nerve that supply the acid-secreting cells in the stomach. It is a highly targeted procedure that reduces gastric acid secretion while minimizing side effects such as delayed gastric emptying and diarrhea.

Vagotomy is typically performed using laparoscopic or open surgical techniques, depending on the patient's individual needs and the surgeon's preference. While vagotomy can be effective in treating peptic ulcers, it is not commonly performed today due to the development of less invasive treatments such as proton pump inhibitors (PPIs) that reduce gastric acid secretion without surgery.

A proximal gastric vagotomy is a surgical procedure that involves selectively cutting the vagus nerve (the tenth cranial nerve) close to its origin in the stomach. The vagus nerve plays an important role in controlling the motor functions and secretions of the gastrointestinal tract, including the stomach.

In a proximal gastric vagotomy, the nerve branches that innervate the proximal part of the stomach are selectively cut, which reduces acid secretion from the stomach. This type of vagotomy is often performed as part of a surgical treatment for peptic ulcers, particularly those located in the upper part of the stomach or in the duodenum (the first section of the small intestine).

It's worth noting that there are different types of vagotomies, and the specific type used depends on the individual patient's needs and medical history. Other types of vagotomy include truncal vagotomy, selective vagotomy, and highly selective vagotomy. Each of these procedures has its own advantages and disadvantages, and the choice of procedure depends on various factors such as the location and severity of the ulcer, the patient's overall health, and the risk of complications.

Cholecystokinin (CCK) is a hormone that is produced in the duodenum (the first part of the small intestine) and in the brain. It is released into the bloodstream in response to food, particularly fatty foods, and plays several roles in the digestive process.

In the digestive system, CCK stimulates the contraction of the gallbladder, which releases bile into the small intestine to help digest fats. It also inhibits the release of acid from the stomach and slows down the movement of food through the intestines.

In the brain, CCK acts as a neurotransmitter and has been shown to have effects on appetite regulation, mood, and memory. It may play a role in the feeling of fullness or satiety after eating, and may also be involved in anxiety and panic disorders.

CCK is sometimes referred to as "gallbladder-stimulating hormone" or "pancreozymin," although these terms are less commonly used than "cholecystokinin."

Devazepide is not a medical term, but it is a pharmaceutical compound. It is a selective and competitive antagonist of the benzodiazepine site on GABA(A) receptors. This means that devazepide blocks the effects of benzodiazepines by binding to the same site on the GABA(A) receptor without activating it.

Devazepide has been studied in research settings as a potential treatment for alcohol use disorder and anxiety disorders, but it is not currently approved for medical use in any country.

Therefore, there is no official medical definition for 'Devazepide'.

A chemical stimulation in a medical context refers to the process of activating or enhancing physiological or psychological responses in the body using chemical substances. These chemicals can interact with receptors on cells to trigger specific reactions, such as neurotransmitters and hormones that transmit signals within the nervous system and endocrine system.

Examples of chemical stimulation include the use of medications, drugs, or supplements that affect mood, alertness, pain perception, or other bodily functions. For instance, caffeine can chemically stimulate the central nervous system to increase alertness and decrease feelings of fatigue. Similarly, certain painkillers can chemically stimulate opioid receptors in the brain to reduce the perception of pain.

It's important to note that while chemical stimulation can have therapeutic benefits, it can also have adverse effects if used improperly or in excessive amounts. Therefore, it's essential to follow proper dosing instructions and consult with a healthcare provider before using any chemical substances for stimulation purposes.

Tetragastrin is not a medical condition but a synthetic peptide hormone that is used in medical research and diagnostic tests. It is composed of four amino acids (glutamic acid, proline, tryptophan, and methionine) and is similar to the natural hormone gastrin, which is produced by the stomach and helps regulate digestion.

Tetragastrin is used in medical research to study the function of the stomach and intestines, and it is also used in diagnostic tests to stimulate the release of gastric acid from the stomach. This can help diagnose conditions such as pernicious anemia, a condition in which the body cannot absorb vitamin B12 due to a lack of intrinsic factor, a protein produced by the stomach.

In summary, Tetragastrin is a synthetic hormone that mimics the function of natural gastrin and is used for research and diagnostic purposes related to the digestive system.

Bethanechol is a parasympathomimetic drug, which means it stimulates the parasympathetic nervous system. This system is responsible for regulating many automatic functions in the body, including digestion and urination. Bethanechol works by causing the smooth muscles of the bladder to contract, which can help to promote urination in people who have difficulty emptying their bladder completely due to certain medical conditions such as surgery, spinal cord injury, or multiple sclerosis.

The medical definition of 'Bethanechol' is:

A parasympathomimetic agent that stimulates the muscarinic receptors of the autonomic nervous system, causing contraction of smooth muscle and increased secretion of exocrine glands. It is used to treat urinary retention and associated symptoms, such as those caused by bladder-neck obstruction due to prostatic hypertrophy or neurogenic bladder dysfunction. Bethanechol may also be used to diagnose urinary tract obstruction and to test the integrity of the bladder's innervation.

Secretin is a hormone that is produced and released by the S cells in the duodenum, which is the first part of the small intestine. It is released in response to the presence of acidic chyme (partially digested food) entering the duodenum from the stomach. Secretin stimulates the pancreas to produce bicarbonate-rich alkaline secretions, which help neutralize the acidity of the chyme and create an optimal environment for enzymatic digestion in the small intestine.

Additionally, secretin also promotes the production of watery fluids from the liver, which aids in the digestion process. Overall, secretin plays a crucial role in maintaining the pH balance and facilitating proper nutrient absorption in the gastrointestinal tract.

A gastric fistula is an abnormal connection or passage between the stomach and another organ or the skin surface. This condition can occur as a result of complications from surgery, injury, infection, or certain diseases such as cancer. Symptoms may include persistent drainage from the site of the fistula, pain, malnutrition, and infection. Treatment typically involves surgical repair of the fistula and management of any underlying conditions.

The Alfaxalone Alfadolone Mixture is a veterinary anesthetic agent, which contains two active ingredients: alfaxalone and alfadolone. Both are neuroactive steroids that depress the central nervous system, leading to sedation, muscle relaxation, and eventually anesthesia.

The mixture is used for induction and maintenance of anesthesia in various animal species, including dogs, cats, and horses. It provides smooth induction and rapid recovery from anesthesia, making it a popular choice among veterinarians. However, as with any anesthetic agent, there are potential risks and side effects associated with its use, such as respiratory depression, cardiovascular depression, and apnea. Proper dosing, monitoring, and management are essential to ensure the safety and efficacy of this anesthetic agent in veterinary medicine.

Gastric acidity determination is a medical test used to measure the amount of acid in the stomach. This test is often performed to diagnose or monitor conditions such as gastritis, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome. The test involves measuring the pH level of the stomach contents using a thin, flexible tube called a catheter that is passed through the nose and down into the stomach. In some cases, a small sample of stomach fluid may also be collected for further testing.

The normal range for gastric acidity is typically considered to be a pH level below 4. A higher pH level may indicate that the stomach is producing too little acid, while a lower pH level may suggest that it is producing too much. Based on the results of the test, healthcare providers can develop an appropriate treatment plan for the underlying condition causing abnormal gastric acidity.

Atropine is an anticholinergic drug that blocks the action of the neurotransmitter acetylcholine in the central and peripheral nervous system. It is derived from the belladonna alkaloids, which are found in plants such as deadly nightshade (Atropa belladonna), Jimson weed (Datura stramonium), and Duboisia spp.

In clinical medicine, atropine is used to reduce secretions, increase heart rate, and dilate the pupils. It is often used before surgery to dry up secretions in the mouth, throat, and lungs, and to reduce salivation during the procedure. Atropine is also used to treat certain types of nerve agent and pesticide poisoning, as well as to manage bradycardia (slow heart rate) and hypotension (low blood pressure) caused by beta-blockers or calcium channel blockers.

Atropine can have several side effects, including dry mouth, blurred vision, dizziness, confusion, and difficulty urinating. In high doses, it can cause delirium, hallucinations, and seizures. Atropine should be used with caution in patients with glaucoma, prostatic hypertrophy, or other conditions that may be exacerbated by its anticholinergic effects.

The esophagogastric junction (EGJ) is the region of the gastrointestinal tract where the esophagus (the tube that carries food from the mouth to the stomach) meets the stomach. It serves as a physiological sphincter, which helps control the direction of flow and prevent reflux of gastric contents back into the esophagus. The EGJ is also known as the gastroesophageal junction or cardia.

Cholecystokinin B (CCK-B) receptor is a type of G protein-coupled receptor that binds the hormone cholecystokinin (CCK). CCK is a peptide hormone that is released by cells in the duodenum in response to food intake, particularly fat and protein. The binding of CCK to the CCK-B receptor triggers several physiological responses, including contraction of the gallbladder and relaxation of the sphincter of Oddi, which controls the flow of bile and pancreatic juices into the duodenum.

The CCK-B receptor is primarily found in the gastrointestinal tract, particularly in the smooth muscle cells of the gallbladder and the sphincter of Oddi. It is also expressed in the central nervous system (CNS), where it plays a role in regulating appetite and satiety.

The activation of CCK-B receptors in the CNS has been shown to reduce food intake, making it a potential target for the development of anti-obesity drugs. However, the use of CCK-B receptor agonists as therapeutic agents is limited by their side effects, which include nausea and abdominal pain.

Cimetidine is a histamine-2 (H2) receptor antagonist, which is a type of medication that reduces the production of stomach acid. It works by blocking the action of histamine on the H2 receptors in the stomach, which are responsible for stimulating the release of stomach acid. By blocking these receptors, cimetidine reduces the amount of stomach acid produced and can help to relieve symptoms such as heartburn, indigestion, and stomach ulcers.

Cimetidine is available by prescription in various forms, including tablets, capsules, and liquid. It is typically taken two or three times a day, depending on the specific condition being treated. Common side effects of cimetidine may include headache, dizziness, diarrhea, and constipation.

In addition to its use in treating stomach acid-related conditions, cimetidine has also been studied for its potential anti-cancer properties. Some research suggests that it may help to enhance the immune system's response to cancer cells and reduce the growth of certain types of tumors. However, more research is needed to confirm these effects and determine the optimal dosage and duration of treatment.

Calcitonin is a hormone that is produced and released by the parafollicular cells (also known as C cells) of the thyroid gland. It plays a crucial role in regulating calcium homeostasis in the body. Specifically, it helps to lower elevated levels of calcium in the blood by inhibiting the activity of osteoclasts, which are bone cells that break down bone tissue and release calcium into the bloodstream. Calcitonin also promotes the uptake of calcium in the bones and increases the excretion of calcium in the urine.

Calcitonin is typically released in response to high levels of calcium in the blood, and its effects help to bring calcium levels back into balance. In addition to its role in calcium regulation, calcitonin may also have other functions in the body, such as modulating immune function and reducing inflammation.

Clinically, synthetic forms of calcitonin are sometimes used as a medication to treat conditions related to abnormal calcium levels, such as hypercalcemia (high blood calcium) or osteoporosis. Calcitonin can be administered as an injection, nasal spray, or oral tablet, depending on the specific formulation and intended use.

Sincalide is a synthetic hormone that stimulates the contraction of the gallbladder and the release of digestive enzymes from the pancreas. It is used in diagnostic procedures to help diagnose conditions such as gallstones or obstructions of the bile ducts.

Sincalide is a synthetic form of cholecystokinin (CCK), a hormone that is naturally produced in the body and stimulates the contraction of the gallbladder and the release of digestive enzymes from the pancreas. When sincalide is administered, it mimics the effects of CCK and causes the gallbladder to contract and release bile into the small intestine. This can help doctors see if there are any obstructions or abnormalities in the bile ducts or gallbladder.

Sincalide is usually given as an injection, and its effects can be monitored through imaging tests such as ultrasound or CT scans. It is important to note that sincalide should only be used under the supervision of a healthcare professional, as it can cause side effects such as abdominal pain, nausea, and vomiting.

Thiourea is not a medical term, but a chemical compound. It's a colorless crystalline solid with the formula SC(NH2)2. Thiourea is used in some industrial processes and can be found in some laboratory reagents. It has been studied for its potential effects on certain medical conditions, such as its ability to protect against radiation damage, but it is not a medication or a treatment that is currently in clinical use.

Peptones are not a medical term per se, but they are commonly used in medical and clinical laboratory settings. Peptones are complex organic compounds that result from the partial hydrolysis of proteins. They consist of a mixture of polypeptides, peptides, and free amino acids.

In medical laboratories, peptones are often used as a nutrient source in various culture media for the growth of microorganisms such as bacteria and fungi. Peptone water is a common liquid medium used to culture and isolate bacteria. It contains peptones, sodium chloride, and other ingredients that provide essential nutrients for bacterial growth.

Peptones are also used in biochemical tests to identify specific microorganisms based on their ability to metabolize certain components of the peptone. For example, in the sulfur-indole-motility (SIM) medium, peptones serve as a source of amino acids and other nutrients that support the growth of bacteria producing enzymes responsible for the production of indole from tryptophan.

Esophageal achalasia is a rare disorder of the esophagus, the tube that carries food from the mouth to the stomach. In this condition, the muscles at the lower end of the esophagus fail to relax properly during swallowing, making it difficult for food and liquids to pass into the stomach. This results in symptoms such as difficulty swallowing (dysphagia), regurgitation of food, chest pain, and weight loss. The cause of esophageal achalasia is not fully understood, but it is believed to be related to damage to the nerves that control the muscles of the esophagus. Treatment options include medications to relax the lower esophageal sphincter, botulinum toxin injections, and surgical procedures such as laparoscopic Heller myotomy or peroral endoscopic myotomy (POEM).

The duodenum is the first part of the small intestine, immediately following the stomach. It is a C-shaped structure that is about 10-12 inches long and is responsible for continuing the digestion process that begins in the stomach. The duodenum receives partially digested food from the stomach through the pyloric valve and mixes it with digestive enzymes and bile produced by the pancreas and liver, respectively. These enzymes help break down proteins, fats, and carbohydrates into smaller molecules, allowing for efficient absorption in the remaining sections of the small intestine.

Histamine H2 antagonists, also known as H2 blockers, are a class of medications that work by blocking the action of histamine on the H2 receptors in the stomach. Histamine is a chemical that is released by the body during an allergic reaction and can also be released by certain cells in the stomach in response to food or other stimuli. When histamine binds to the H2 receptors in the stomach, it triggers the release of acid. By blocking the action of histamine on these receptors, H2 antagonists reduce the amount of acid produced by the stomach, which can help to relieve symptoms such as heartburn, indigestion, and stomach ulcers. Examples of H2 antagonists include ranitidine (Zantac), famotidine (Pepcid), and cimetidine (Tagamet).

Malignant carcinoid syndrome is a complex of symptoms that occur in some people with malignant tumors (carcinoids) that secrete large amounts of hormone-like substances, particularly serotonin. These symptoms can include flushing of the face and upper body, diarrhea, rapid heartbeat, difficulty breathing, and abdominal pain and distention. In addition, these individuals may have chronic inflammation of the heart valves (endocarditis) leading to heart failure. It is important to note that not all people with carcinoid tumors will develop malignant carcinoid syndrome, but those who do require specific treatment for their symptoms and hormonal imbalances.

Panic, in a medical context, refers to an intense and sudden episode of fear or discomfort that reaches a peak within minutes, accompanied by physical reactions such as increased heart rate, rapid breathing (hyperventilation), trembling, shaking, and potentially causing a feeling of losing control or going crazy. It's often a symptom of panic disorder or another anxiety disorder. A single panic attack doesn't necessarily mean a person has a panic disorder, but repeated attacks may indicate this condition.

Somatostatin is a hormone that inhibits the release of several hormones and also has a role in slowing down digestion. It is produced by the body in various parts of the body, including the hypothalamus (a part of the brain), the pancreas, and the gastrointestinal tract.

Somatostatin exists in two forms: somatostatin-14 and somatostatin-28, which differ in their length. Somatostatin-14 is the predominant form found in the brain, while somatostatin-28 is the major form found in the gastrointestinal tract.

Somatostatin has a wide range of effects on various physiological processes, including:

* Inhibiting the release of several hormones such as growth hormone, insulin, glucagon, and gastrin
* Slowing down digestion by inhibiting the release of digestive enzymes from the pancreas and reducing blood flow to the gastrointestinal tract
* Regulating neurotransmission in the brain

Somatostatin is used clinically as a diagnostic tool for detecting certain types of tumors that overproduce growth hormone or other hormones, and it is also used as a treatment for some conditions such as acromegaly (a condition characterized by excessive growth hormone production) and gastrointestinal disorders.

I believe there might be a misunderstanding in your question. "Dogs" is not a medical term or condition. It is the common name for a domesticated carnivore of the family Canidae, specifically the genus Canis, which includes wolves, foxes, and other extant and extinct species of mammals. Dogs are often kept as pets and companions, and they have been bred in a wide variety of forms and sizes for different purposes, such as hunting, herding, guarding, assisting police and military forces, and providing companionship and emotional support.

If you meant to ask about a specific medical condition or term related to dogs, please provide more context so I can give you an accurate answer.

Histamine release is the process by which mast cells and basophils (types of white blood cells) release histamine, a type of chemical messenger or mediator, into the surrounding tissue fluid in response to an antigen-antibody reaction. This process is a key part of the body's immune response to foreign substances, such as allergens, and helps to initiate local inflammation, increase blood flow, and recruit other immune cells to the site of the reaction.

Histamine release can also occur in response to certain medications, physical trauma, or other stimuli. When histamine is released in large amounts, it can cause symptoms such as itching, sneezing, runny nose, watery eyes, and hives. In severe cases, it can lead to anaphylaxis, a life-threatening allergic reaction that requires immediate medical attention.

Hexamethonium compounds are a type of ganglionic blocker, which are medications that block the transmission of nerve impulses at the ganglia ( clusters of nerve cells) in the autonomic nervous system. These compounds contain hexamethonium as the active ingredient, which is a compound with the chemical formula C16H32N2O4.

Hexamethonium works by blocking the nicotinic acetylcholine receptors at the ganglia, which prevents the release of neurotransmitters and ultimately inhibits the transmission of nerve impulses. This can have various effects on the body, depending on which part of the autonomic nervous system is affected.

Hexamethonium compounds were once used to treat hypertension (high blood pressure), but they are rarely used today due to their numerous side effects and the availability of safer and more effective medications. Some of the side effects associated with hexamethonium include dry mouth, blurred vision, constipation, difficulty urinating, and dizziness upon standing.

Intestinal secretions refer to the fluids and electrolytes that are released by the cells lining the small intestine in response to various stimuli. These secretions play a crucial role in the digestion and absorption of nutrients from food. The major components of intestinal secretions include water, electrolytes (such as sodium, chloride, bicarbonate, and potassium), and enzymes that help break down carbohydrates, proteins, and fats.

The small intestine secretes these substances in response to hormonal signals, neural stimulation, and the presence of food in the lumen of the intestine. The secretion of water and electrolytes helps maintain the proper hydration and pH of the intestinal contents, while the enzymes facilitate the breakdown of nutrients into smaller molecules that can be absorbed across the intestinal wall.

Abnormalities in intestinal secretions can lead to various gastrointestinal disorders, such as diarrhea, malabsorption, and inflammatory bowel disease.

In medical terms, pressure is defined as the force applied per unit area on an object or body surface. It is often measured in millimeters of mercury (mmHg) in clinical settings. For example, blood pressure is the force exerted by circulating blood on the walls of the arteries and is recorded as two numbers: systolic pressure (when the heart beats and pushes blood out) and diastolic pressure (when the heart rests between beats).

Pressure can also refer to the pressure exerted on a wound or incision to help control bleeding, or the pressure inside the skull or spinal canal. High or low pressure in different body systems can indicate various medical conditions and require appropriate treatment.

The gastric fundus is the upper, rounded portion of the stomach that lies above the level of the cardiac orifice and extends up to the left dome-shaped part of the diaphragm. It is the part of the stomach where food and liquids are first stored after entering through the esophagus. The gastric fundus contains parietal cells, which secrete hydrochloric acid, and chief cells, which produce pepsinogen, a precursor to the digestive enzyme pepsin. It is also the site where the hormone ghrelin is produced, which stimulates appetite.

Omeprazole is defined as a proton pump inhibitor (PPI) used in the treatment of gastroesophageal reflux disease (GERD), gastric ulcers, and other conditions where reducing stomach acid is desired. It works by blocking the action of the proton pumps in the stomach, which are responsible for producing stomach acid. By inhibiting these pumps, omeprazole reduces the amount of acid produced in the stomach, providing relief from symptoms such as heartburn and pain caused by excess stomach acid.

It is available in various forms, including tablets, capsules, and oral suspension, and is typically taken once or twice a day, depending on the condition being treated. As with any medication, omeprazole should be used under the guidance of a healthcare professional, and its potential side effects and interactions with other medications should be carefully considered before use.

A dose-response relationship in the context of drugs refers to the changes in the effects or symptoms that occur as the dose of a drug is increased or decreased. Generally, as the dose of a drug is increased, the severity or intensity of its effects also increases. Conversely, as the dose is decreased, the effects of the drug become less severe or may disappear altogether.

The dose-response relationship is an important concept in pharmacology and toxicology because it helps to establish the safe and effective dosage range for a drug. By understanding how changes in the dose of a drug affect its therapeutic and adverse effects, healthcare providers can optimize treatment plans for their patients while minimizing the risk of harm.

The dose-response relationship is typically depicted as a curve that shows the relationship between the dose of a drug and its effect. The shape of the curve may vary depending on the drug and the specific effect being measured. Some drugs may have a steep dose-response curve, meaning that small changes in the dose can result in large differences in the effect. Other drugs may have a more gradual dose-response curve, where larger changes in the dose are needed to produce significant effects.

In addition to helping establish safe and effective dosages, the dose-response relationship is also used to evaluate the potential therapeutic benefits and risks of new drugs during clinical trials. By systematically testing different doses of a drug in controlled studies, researchers can identify the optimal dosage range for the drug and assess its safety and efficacy.

I couldn't find a medical definition for "Depression, Chemical" as it is not a recognized medical term. However, I can provide you with information about chemical imbalances in the brain that are associated with depression.

Major depressive disorder (MDD), commonly referred to as depression, is believed to be caused by a combination of genetic, environmental, and physiological factors. While there is no definitive evidence that depression is solely caused by a "chemical imbalance," neurotransmitter irregularities in the brain are associated with depressive symptoms. Neurotransmitters are chemical messengers that transmit signals in the brain and other parts of the body. Some of the primary neurotransmitters involved in mood regulation include serotonin, norepinephrine, and dopamine.

In depression, it is thought that there may be alterations in the functioning of these neurotransmitter systems, leading to an imbalance. For example:

1. Serotonin: Low levels of serotonin are associated with depressive symptoms. Selective serotonin reuptake inhibitors (SSRIs), a common class of antidepressants, work by increasing the availability of serotonin in the synapse (the space between neurons) to improve communication between brain cells.
2. Norepinephrine: Imbalances in norepinephrine levels can contribute to depressive symptoms and anxiety. Norepinephrine reuptake inhibitors (NRIs), tricyclic antidepressants (TCAs), and monoamine oxidase inhibitors (MAOIs) are medications that target norepinephrine to help alleviate depression.
3. Dopamine: Deficiencies in dopamine can lead to depressive symptoms, anhedonia (the inability to feel pleasure), and motivation loss. Some antidepressants, like bupropion, work by increasing dopamine levels in the brain.

In summary, while "Chemical Depression" is not a recognized medical term, chemical imbalances in neurotransmitter systems are associated with depressive symptoms. However, depression is a complex disorder that cannot be solely attributed to a single cause or a simple chemical imbalance. It is essential to consider multiple factors when diagnosing and treating depression.

Histamine H1 antagonists, also known as H1 blockers or antihistamines, are a class of medications that work by blocking the action of histamine at the H1 receptor. Histamine is a chemical mediator released by mast cells and basophils in response to an allergic reaction or injury. It causes various symptoms such as itching, sneezing, runny nose, and wheal and flare reactions (hives).

H1 antagonists prevent the binding of histamine to its receptor, thereby alleviating these symptoms. They are commonly used to treat allergic conditions such as hay fever, hives, and eczema, as well as motion sickness and insomnia. Examples of H1 antagonists include diphenhydramine (Benadryl), loratadine (Claritin), cetirizine (Zyrtec), and doxylamine (Unisom).

Gastrointestinal (GI) hormones are a group of hormones that are secreted by cells in the gastrointestinal tract in response to food intake and digestion. They play crucial roles in regulating various physiological processes, including appetite regulation, gastric acid secretion, motility of the gastrointestinal tract, insulin secretion, and pancreatic enzyme release.

Examples of GI hormones include:

* Gastrin: Secreted by G cells in the stomach, gastrin stimulates the release of hydrochloric acid from parietal cells in the stomach lining.
* Ghrelin: Produced by the stomach, ghrelin is often referred to as the "hunger hormone" because it stimulates appetite and food intake.
* Cholecystokinin (CCK): Secreted by I cells in the small intestine, CCK promotes digestion by stimulating the release of pancreatic enzymes and bile from the liver. It also inhibits gastric emptying and reduces appetite.
* Gastric inhibitory peptide (GIP): Produced by K cells in the small intestine, GIP promotes insulin secretion and inhibits glucagon release.
* Secretin: Released by S cells in the small intestine, secretin stimulates the pancreas to produce bicarbonate-rich fluid that neutralizes stomach acid in the duodenum.
* Motilin: Secreted by MO cells in the small intestine, motilin promotes gastrointestinal motility and regulates the migrating motor complex (MMC), which is responsible for cleaning out the small intestine between meals.

These hormones work together to regulate digestion and maintain homeostasis in the body. Dysregulation of GI hormones can contribute to various gastrointestinal disorders, such as gastroparesis, irritable bowel syndrome (IBS), and diabetes.

Pancreatic polypeptide (PP) is a hormone that is produced and released by the pancreas, specifically by the F cells located in the islets of Langerhans. It is a small protein consisting of 36 amino acids, and it plays a role in regulating digestive functions, particularly by inhibiting pancreatic enzyme secretion and gastric acid secretion.

PP is released into the bloodstream in response to food intake, especially when nutrients such as proteins and fats are present in the stomach. It acts on the brain to produce a feeling of fullness or satiety, which helps to regulate appetite and eating behavior. Additionally, PP has been shown to have effects on glucose metabolism, insulin secretion, and energy balance.

In recent years, there has been growing interest in the potential therapeutic uses of PP for a variety of conditions, including obesity, diabetes, and gastrointestinal disorders. However, more research is needed to fully understand its mechanisms of action and clinical applications.

Achlorhydria is a medical condition characterized by the absence or near-absence of hydrochloric acid in the stomach. Hydrochloric acid is a digestive fluid that helps to break down food, particularly proteins, and also creates an acidic environment that prevents harmful bacteria from growing in the stomach.

Achlorhydria can be caused by various factors, including certain medications, autoimmune disorders, aging, or surgical removal of the stomach. Symptoms of achlorhydria may include indigestion, bloating, abdominal pain, and malabsorption of nutrients. If left untreated, it can lead to complications such as anemia, vitamin B12 deficiency, and increased risk of gastrointestinal infections.

It is important to note that achlorhydria can be diagnosed through various tests, including a gastric acid analysis or a pH test. Treatment for achlorhydria may involve supplementing with hydrochloric acid or other digestive enzymes, modifying the diet, and addressing any underlying conditions.

... and has been used as a diagnostic aid as the pentagastrin-stimulated calcitonin test. Pentagastrin binds to the cholecystokinin ... Pentagastrin's IUPAC chemical name is "N-((1,1-dimethylethoxy)carbonyl)-beta-alanyl-L-tryptophyl-L-methionyl-L-alpha-aspartyl-L ... The pentagastrin-stimulated calcitonin test is useful in cases of suspected MTC that are not associated with elevated ... Braganza JM, Herman K, Hine P, Kay G (April 1979). "The effect of pentagastrin (I.C.I. 50, 123) on peptic secretion in man". ...
Pentagastrin, a synthetic gastrin, histamine, and acetylcholine are also gastric secretagogues. Insulin secretagogues, such as ...
Secretion of calcitonin is stimulated by: an increase in serum [Ca2+] gastrin and pentagastrin. The hormone participates in ...
To investigate for hypergastrinemia high blood levels of gastrin, a "pentagastrin test" can be performed. In autoimmune ... May impact lower esophageal sphincter (LES) tone, causing it to contract, - although pentagastrin, rather than endogenous ... pentagastrin is an artificially synthesized, five amino acid sequence identical to the last five amino acid sequence at the C- ...
Pentagastrin Eser D, di Michele F, Zwanzger P, Pasini A, Baghai TC, Schüle C, et al. (January 2005). "Panic induction with ...
... inhibits pentagastrin-stimulated gastric acid secretion in conscious rats. Regulatory Peptides, 38:199-206, (1992). Mungan Z, ... Ozmen V, Ertan A, Coy DH, Baylor LM, Rice JC, Rossowski WJ: Structural requirements for galanin inhibition of pentagastrin- ...
Lorglumide Loxiglumide Pranazepide Proglumide Tarazepide Tomoglumide Agonists Cholecystokinin CCK-4 Gastrin Pentagastrin (CCK-5 ...
... pentagastrin MeSH D06.472.317.413.800 - tetragastrin MeSH D06.472.317.469 - glucagon precursors MeSH D06.472.317.469.500 - ...
... gastrin and pentagastrin, as well as the presence of food. In the duodenum, proteases digest R-proteins and release their bound ...
... pentagastrin (INN) pentagestrone (INN) pentalamide (INN) Pentam pentamethonium bromide (INN) pentamidine (INN) pentamorphone ( ...
... demonstrated a link between milk consumption and an increase in gastrin production almost equivalent to that of pentagastrin, ...
V04CF01 Tuberculin V04CG01 Cation exchange resins V04CG02 Betazole V04CG03 Histamine phosphate V04CG04 Pentagastrin V04CG05 ...
... developed a new type of histamine antagonist capable of inhibiting gastric acid secretion induced by histamine or pentagastrin ...
Infused at Near-Physiological Concentrations on Pentagastrin-Stimulated Gastric Acid Secretion in Normal Human Subjects". ...
H 2 -histamine receptor blockers can counteract the effects of pentagastrin a and histamine a on gastric acid-forming function ...
... pentagastrin MeSH D12.644.456.724 - pepstatins MeSH D12.644.456.726 - peptichemio MeSH D12.644.456.729 - peptide t MeSH D12.644 ...
... and has been used as a diagnostic aid as the pentagastrin-stimulated calcitonin test. Pentagastrin binds to the cholecystokinin ... Pentagastrins IUPAC chemical name is "N-((1,1-dimethylethoxy)carbonyl)-beta-alanyl-L-tryptophyl-L-methionyl-L-alpha-aspartyl-L ... The pentagastrin-stimulated calcitonin test is useful in cases of suspected MTC that are not associated with elevated ... Braganza JM, Herman K, Hine P, Kay G (April 1979). "The effect of pentagastrin (I.C.I. 50, 123) on peptic secretion in man". ...
Gati, T. 1976: Effect of histamine and penta gastrin on carbo anhydrase activity of the gastric mucosa in the rat Acta ... Zimonina, T.V. 1973: Effect of penta gastrin histamine and cyclic amp on the carbonic anhydrase activity in the gastric mucosa ... Geisbe, H. 1971: The effect of histamine carbachol and penta gastrin on gastric acid secretion in miniature pigs Naunyn- ... Ruoff H J.; Sewing K F. 1973: Cyclic amp in the rat gastric mucosa after starvation feeding and penta gastrin Scandinavian ...
Elabscience provides competitively priced and strictly inspected Pentagastrin for your researches. ...
The effect of intra-amygdala infusions of pentagastrin (0, 0.01, 0.1, 1, and 10 nm) on locomotor activity. Pentagastrin had no ... Experiment 2: effect of intra-amygdala infusions of pentagastrin on locomotion. Intra-amygdala infusions of pentagastrin (0, ... Rats were then removed and infused with pentagastrin [0 nm (n = 6), 0.01 nm (n = 8), 0.1 nm(n = 10), 1 nm (n = 8), or 10 nm (n ... pentagastrin infusions. Startle responses (±SEM) are shown across time. All rats received i.c.v. infusions of pentagastrin (100 ...
Patients with panic disorder showed an exaggerated ACTH response to pentagastrin stimulation, but this response was normalized ...
Intrinsic Factor: Oral Ranitidine Tablets, USP have no significant effect on pentagastrin-stimulated intrinsic factor secretion ... while pentagastrin- and food-stimulated secretions are more difficult to suppress. ...
Pentagastrin (JAN/USAN/INN). D01648 Hyoscyamine methylbromide (JAN). D01815 Oxapium iodide (JP18/INN). ...
In the stomach, VIP inhibits histamine- and pentagastrin-stimulated acid secretion. Like glucagon, VIP stimulates lipolysis and ...
It does not increase or decrease basal or pentagastrin-induced gastric acid secretion. ...
Pentagastrin test for anxiety--psychophysiology and personality. Radu, D., Ahlin, A., Svanborg, P., Lindefors, N. ... CONCLUSIONS: We found correlations between psychophysiology, humoral response and subjective ratings following pentagastrin ...
Dissociation was also rapid, with the rate similar after 100-fold dilution or dilution plus excess pentagastrin. At a tracer ... and binding in the presence of excess pentagastrin accounted for 11% of total binding. G17 and carboxyl terminal octapeptide of ...
In patients with hypersecretion of acid, lansoprazole significantly reduced basal and pentagastrin-stimulated gastric acid ... as well as pentagastrin-stimulated acid output. ...
... and pentagastrin. Cimetidine is also helpful in treating upper gastrointestinal bleeding in critically ill patients. Side ...
... on basal and pentagastrin-stimulated gastric secretion]. Rev Esp.Enferm.Dig. 1993;83:55-56. View abstract. ...
... disease patients in response to graded doses of pentagastrin and pentagastrin plus bethanecol. Digestion, 23: 48-56, 1982. ...
... and endoscopic mucosal biopsy techniques during hormonal stimulation with pentagastrin and cholecystokinin 8. ...
... and pentagastrin. Doses of 6-36 mg/kg administered orally four to five hours before the secretagogues produced a dose-dependant ...
1. Lind T, Cederberg C, Ekenved G, Haglund U, Olbe L. Effect of omeprazole-a gastric proton pump inhibitor-on pentagastrin ...
PENTAGASTRIN 54290 PENTAZOCINE 54295 PENTOBARBITAL 54297 PENTOXIFYLLINE 54300 PENTYLENETETRAZOL 54305 PEPPERMINT 54310 PEPSIN ...
Regulation of oxygen uptake in resting and pentagastrin stimulated stomach. Am J Physiol. 1982. 242: G565-9 ...
... already suspected by the highly sensitive pentagastrin diagnostic test (5-7). Of particular clinical relevance is the ...
C. 6 μg/kg of pentagastrin 5-10 min before the study. ...
The only specific criteria to diagnose pernicious anemia is an intrinsic factor output of less than 200U/h after pentagastrin ...
Basal and pentagastrin-stimulated gastric secretions, collected (at 15-min intervals for 1 h) from six duodenal ulcer and six ... N2 - Basal and pentagastrin-stimulated gastric secretions, collected (at 15-min intervals for 1 h) from six duodenal ulcer and ... AB - Basal and pentagastrin-stimulated gastric secretions, collected (at 15-min intervals for 1 h) from six duodenal ulcer and ... abstract = "Basal and pentagastrin-stimulated gastric secretions, collected (at 15-min intervals for 1 h) from six duodenal ...
... and pentagastrin.5,6 ...
... pentagastrin; gastric inhibitory peptide 1-30, porcine; gastric inhibitory peptide 1-30, amide, porcine; [Tyr0]-gastric ...
Pentagastrin. 6 mcg/kg/hr (iv). 100 mg/hr (iv). 60% at 1 hour. ... pentagastrin, caffeine and insulin as follows:. Stimulant ... Manomet also inhibits gastric acid secretion stimulated by food, histamine, pentagastrin, caffeine and insulin.. Antisecretory ...
... while pentagastrin- and food-stimulated secretions are more difficult to suppress. ...
Cardiometabolic Diseases | We hold exceptional competence in pharmacodynamic assessments of metabolic diseases under new medicines.
Gastric acid and pepsin secretions were stimulated with pentagastrin. Expressed in terms of exogenous doses, SS-14 (ID50: 1.49 ... Gastric acid and pepsin secretions were stimulated with pentagastrin. Expressed in terms of exogenous doses, SS-14 (ID50: 1.49 ... Gastric acid and pepsin secretions were stimulated with pentagastrin. Expressed in terms of exogenous doses, SS-14 (ID50: 1.49 ... Gastric acid and pepsin secretions were stimulated with pentagastrin. Expressed in terms of exogenous doses, SS-14 (ID50: 1.49 ...
  • It stimulates the secretion of gastric acid, pepsin, and intrinsic factor, and has been used as a diagnostic aid as the pentagastrin-stimulated calcitonin test. (wikipedia.org)
  • These drugs are used to treat gastric and duodenal ulcers by inhibition of gastric acid secretion stimulated by food, insulin, histamine, caffeine, and pentagastrin. (fsu.edu)
  • Given orally to dogs it reduced gastric acid, pepsin and volume output in response to food, insulin, histamine, N-methyl histamine, and pentagastrin. (bmj.com)
  • 1. Lind T, Cederberg C, Ekenved G, Haglund U, Olbe L. Effect of omeprazole-a gastric proton pump inhibitor-on pentagastrin stimulated acid secretion in man. (acpjournals.org)
  • Basal and pentagastrin-stimulated gastric secretions, collected (at 15-min intervals for 1 h) from six duodenal ulcer and six gastric ulcer patients, were analyzed for their content of lecithin, lysolecithin, and glyceroglucolipids. (researchwithrutgers.com)
  • After pentagastrin stimulation, the lysolecithin concentrations in the secretion from duodenal ulcer patients rose slightly (to 212 μmol/l), whereas a twofold decrease (to 440 μmol/l) in lysolecithin was observed in the secretion from patients with gastric ulcer. (researchwithrutgers.com)
  • Famotidine inhibits both basal and nocturnal gastric acid secretion, as well as acid secretion stimulated by food, caffeine, insulin, and pentagastrin. (drugbank.com)
  • Manomet also inhibits gastric acid secretion stimulated by food, histamine, pentagastrin, caffeine and insulin. (sdrugs.com)
  • Gastric acid and pepsin secretions were stimulated with pentagastrin. (uaeu.ac.ae)
  • Both synthetic somatostatin and pancreatic SLI in a dose of 7-8 μg/kg/h suppressed pentagastrin-stimulated gastric acid secretion. (elsevierpure.com)
  • Effects of ghrelin and esomeprazole, with or without pentagastrin, on gastric pH were studied. (diva-portal.org)
  • It does not affect pepsin secretion, pentagastrin-stimulated intrinsic factor secretion or serum gastrin. (com.bd)
  • In the stomach, VIP inhibits histamine- and pentagastrin-stimulated acid secretion. (medscape.com)
  • Pentagastrin is also used as a stimulation test to elevate of several hormones, such as serotonin. (wikipedia.org)
  • Patients with panic disorder showed an exaggerated ACTH response to pentagastrin stimulation, but this response was normalized by prior exposure to the experimental context or psychological preparation to reduce novelty and enhance sense of control. (nih.gov)
  • Amino acid metabolism, pancreatic enzyme synthesis and secretion, and mucosal protein turnover were measured by primed/continuous intravenous infusion of [1-14C] leucine tracer, duodenal aspiration, and endoscopic mucosal biopsy techniques during hormonal stimulation with pentagastrin and cholecystokinin 8. (nih.gov)
  • Third, infusions of similar doses of pentagastrin into the striatum or nucleus accumbens did not potentiate startle responses. (jneurosci.org)
  • citation needed] The pentagastrin-stimulated calcitonin test is a diagnostic test for medullary carcinoma of the thyroid (MTC). (wikipedia.org)
  • The pentagastrin-stimulated calcitonin test is useful in cases of suspected MTC that are not associated with elevated calcitonin. (wikipedia.org)
  • In these patients, injecting pentagastrin will cause calcitonin levels to rise significantly above the normal or basal range. (wikipedia.org)
  • After a total thyroidectomy for medullary thyroid carcinoma, the pentagastrin-stimulated calcitonin release can be used to detect residual parafollicular C-cells. (wikipedia.org)
  • The C cells, which are derived from the embryonic neural crest, secrete calcitonin in response to an increase in serum calcium or pentagastrin. (touchendocrinology.com)
  • 90%) and high-density expression of CCK-2/gastrin-R (CCK-2/gastrin-R = cholecystokinin subtype 2/gastrin receptor) in human medullary thyroid cancer (MTC), already suspected by the highly sensitive pentagastrin diagnostic test ( 5 - 7 ). (snmjournals.org)
  • Administration of pentagastrin i.v. does not improve the diagnostic accuracy. (endocrinesurgeon.co.uk)
  • Finally, intra-amygdala infusion of the CCK B receptor-selective antagonist PD-135158 (10 μg) blocked the potentiation of startle produced by i.c.v. infusions of pentagastrin, suggesting that i.c.v. infusions of pentagastrin potentiate startle responses via activation of amygdala CCK B receptors. (jneurosci.org)
  • Second, similar infusions of pentagastrin had no effect on locomotor activity over the same time course, showing that increases in startle responsivity after infusions of pentagastrin are not attributable to nonspecific changes in motor activity. (jneurosci.org)
  • Dissociation was also rapid, with the rate similar after 100-fold dilution or dilution plus excess pentagastrin. (jci.org)
  • Substrates used by buy Pentagastrin MRP1 are similar to those for P-gp with the exclusion of taxanes [6]. (scienceexhibitions.org)
  • First, intra-amygdala infusions of the CCK B receptor agonist pentagastrin (0, 0.01, 0.1, 1, and 10 n m ) produced a dose-related potentiation of acoustic startle responses. (jneurosci.org)
  • At a tracer concentration from 10 to 30 pM, saturable binding was 7.8 +/- 0.8% per 10(6) cells (mean +/- SE) and binding in the presence of excess pentagastrin accounted for 11% of total binding. (jci.org)
  • buy Pentagastrin As a total result, the second range of chemotherapy can be not really healing [18]. (scienceexhibitions.org)
  • These methods predicted pentagastrin as a potential antiviral drug against ASFVs. (elsevierpure.com)
  • These results demonstrate that IL-1 beta is an extremely potent inhibitor of acid secretion stimulated by pentagastrin but not that stimulated by histamine or bethanechol, through a mechanism that is at least in part independent of the vagus nerve and of prostaglandin synthesis. (nih.gov)
  • Because pentagastrin-stimulated acid secretion could be completely inhibited by a histamine H2-receptor antagonist (cimetidine) and because IL-1 had no effect on histamine-stimulated acid secretion, it is possible that IL-1 exerts its antisecretory actions by inhibiting pentagastrin-stimulated histamine release. (nih.gov)
  • Cimetidine tablets also inhibit gastric acid secretion stimulated by food, histamine, pentagastrin, caffeine and insulin. (nih.gov)
  • Long-acting and potent H2 receptor antagonist can effectively inhibit gastric acid secretion caused by histamine, pentagastrin and food stimulation, reduce the basic regular gastric acid and inhibit the activity of gastric enzymes. (3gp123.com)
  • Pentagastrin (trade name Peptavlon) is a synthetic polypeptide that has effects like gastrin when given parenterally. (wikipedia.org)
  • An additional group received pentagastrin plus the gastrin receptor antagonist (GRA) L740,093. (psu.edu)
  • The nonselective CCK/gastrin antagonist, proglumide, but not the selective CCK antagonist, asperlicin, antagonized the acid response to both pentagastrin and CCK-8. (eurekamag.com)
  • Measurements had been made previously in 20 subjects of acid output (basal and after pentagastrin) and in 10 subjects of plasma gastrin (basal and after insulin + bicarbonate). (bmj.com)
  • Pentagastrin is also used as a stimulation test to elevate of several hormones, such as serotonin. (wikipedia.org)
  • This test is known as the pentagastrin stimulation test. (medicalhealthtests.com)
  • The Pentagastrin stimulation test is a very popular test and has become the most widely used and accepted stimulation test for CT secretion. (medicalhealthtests.com)
  • In Groups 1A, 1B and 1C, maximal elevation in CT levels was greater after the combined stimulation test than after calcium or pentagastrin tests. (hippokratia.gr)
  • In the present study, the effects of IL-1 beta on pentagastrin-stimulated acid secretion were compared with those of two other cytokines, namely IL-1 alpha and tumor necrosis factor (TNF) alpha. (nih.gov)
  • Inhibition of acid secretion by IL-1 was also observed when the IL-1 was administered subsequent to stimulation by pentagastrin administration. (nih.gov)
  • Pentagastrin administration selectively up-regulates levels of mRNA encoding membrane proteins involved in acid secretion. (psu.edu)
  • Cholecystokinin octapeptide (CCK-8) (EC50 = 5 nM) was considerably more potent than pentagastrin (EC50 = 161 nM) in stimulating acid secretion in the isolated perfused mouse stomach suspended in a medium containing a phosphodiesterase inhibitor. (eurekamag.com)
  • The maximum acid response to CCK-8 was not significantly different from that produced by pentagastrin. (eurekamag.com)
  • In these patients, injecting pentagastrin will cause calcitonin levels to rise significantly above the normal or basal range. (wikipedia.org)
  • Pentagastrin binds to the cholecystokinin-B receptor, which is expressed widely in the brain. (wikipedia.org)
  • Pentagastrin binds itself to a receptor for the cholecystokinin-B. This receptor is largely expressed in the brain. (medicalhealthtests.com)
  • Two groups of Fischer rats received intraperitoneal injections of pentagastrin (2.5 or 25 μg/kg) every 8 hours for three doses. (psu.edu)
  • A double-blind, crossover, placebocontrolled study was conducted in which patients with PD and healthy volunteers received 2 injections of pentagastrin, 7-10 days apart, with randomization of the order of pretreatment with placebo and EE. (jpn.ca)
  • One study reported that provocative testing with pentagastrin produced an increase in VIP plasma levels of 81% over the basal values. (medscape.com)
  • More specifically, some patients have elevated basal CT levels whereas others show an abnormal increase in CT levels only during stimulation tests with various agents, including calcium gluconate (Ca +2 ) and pentagastrin (Pg), which stimulate CT secretion from MTC or C-cell hyperplasia (CCH). (hippokratia.gr)
  • citation needed] The pentagastrin-stimulated calcitonin test is a diagnostic test for medullary carcinoma of the thyroid (MTC). (wikipedia.org)
  • After a total thyroidectomy for medullary thyroid carcinoma, the pentagastrin-stimulated calcitonin release can be used to detect residual parafollicular C-cells. (wikipedia.org)
  • It is equally potent as an inhibitor of pentagastrin-stimulated secretion. (nih.gov)
  • Et andet berømt hormon er insulin, og en stor andel af den globale substitution af dette hormon fremstilles fortsat i Danmark. (ugeskriftet.dk)
  • An in vivo rodent study with the use of famotidine (proton pump inhibitor) and pentagastrin (acidic promoter) was also conducted to evaluate the pH-dependent absorption, and the results aligned with the GastroPlus prediction. (confex.com)
  • For diagnosis purposes, pentagastrin stimulation is used to elevate the levels of serotonin artificially. (medicalhealthtests.com)
  • 22. The pentagastrin test in the diagnosis of the carcinoid syndrome. (nih.gov)
  • Usually, if pentagastrin is given intravenously, it may cause panic attacks. (medicalhealthtests.com)
  • The primary objective of this study was to assess whether pentagastrin-induced panic symptoms are associated with release of free fatty acids (FFAs) in a manner that could explain the mechanism of correlations observed between serum cholesterol levels and frequency and severity of panic attacks in patients with panic disorder (PD). (jpn.ca)
  • We aimed to compare CT stimulation tests with calcium, pentagastrin and their combination in identifying minimal residual MTC and CCH. (hippokratia.gr)
  • We performed 54 combined (calcium plus pentagastrin) stimulation tests, 35 calcium stimulation tests and 26 pentagastrin stimulation tests. (hippokratia.gr)
  • The C cells, which are derived from the embryonic neural crest, secrete calcitonin in response to an increase in serum calcium or pentagastrin. (touchendocrinology.com)
  • Pentagastrin is a polypeptide which does not occur naturally in the body and is procured synthetically. (medicalhealthtests.com)
  • The pentagastrin-stimulated calcitonin test is useful in cases of suspected MTC that are not associated with elevated calcitonin. (wikipedia.org)
  • The pentagastrin test is better in this situation. (endocrinesurgeon.co.uk)
  • At a tracer concentration from 10 to 30 pM, saturable binding was 7.8 +/- 0.8% per 10(6) cells (mean +/- SE) and binding in the presence of excess pentagastrin accounted for 11% of total binding. (jci.org)
  • Administration of pentagastrin caused dose-dependent increases in levels of mRNAs encoding H/K and BSC but had no significant effect on levels of Na/K mRNA. (psu.edu)
  • We hypothesized that pentagastrin administration would affect mRNA levels of two membrane proteins that are important during stimulated states of HC1 secretion, the basolateral Na-K-C1 cotransporter (BSC) and the apical H/K adenosine triphosphatase (H/K). Methods. (psu.edu)
  • Administration of GRA prevented the pentagastrin-induced changes in mRNA levels for these transporters. (psu.edu)
  • We found a statistically significant, time-dependent release of FFAs in response to pentagastrin challenge. (jpn.ca)
  • A secondary objective was to assess whether pretreatment with ethinyl estradiol (EE) attenuates pentagastrin-induced release of FFAs. (jpn.ca)